January 15, 2020 - Page 5 of 5

NASDAQ Companies - January 15, 2020

Phase 3 linzagolix trials expected to generate additional data in uterine fibroids in Q2:20 with first linzagolix regulatory filing planned […]

page 5 of 5

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search